Weed Inc
weedincusa.comWhat Do They Do?
Develops cannabis-derived compounds and strains for medical and industrial uses, targeting research institutions, pharmaceutical companies and cannabis growers. Also holds and markets real estate.
10-K for FY2025, filed Apr 8, 2026Our first business opportunity was, and continues to be, through our wholly-owned subsidiary, Sangre AT, LLC (“Sangre”), where we are…View ↗
Enhanced opportunities for new drug discovery through collaborations with national and international medical research/treatment centers…View ↗
Sangre plans to develop a translational breeding program to establish a new collection of Cannabis cultivars for the USA national market.…View ↗
A cornerstone of the Company’s stability is its long-term real estate holdings. Management continues to maintain and market its high-value…View ↗
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Apr 8, 2026
Who Are Their Customers?
Plans contract work with universities and government agencies, licensed dispensaries and growers, and research collaborations with medical centers and pharmaceutical and related product companies.
10-K for FY2025, filed Apr 8, 2026
How Are They Changing?
Who Do They Compete With?
Competes with Canopy Growth, Aurora, Cronos Group, Trulieve Cannabis, TerrAscend, Tilray Brands, Anandia Labs, Phylos Biosciences, and New West Genetics
10-K for FY2025, filed Apr 8, 2026Canopy Growth Corporation fka Tweed. Symbol: WEED.TO and CGC on the NASDAQ. Canopy Growth changed their symbol on the Toronto Stock…View ↗
Loading...
